An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)

Thomas J. Smith, Patrick J. Coyne, Peter S. Staats, Timothy R. Deer, Lisa Stearns, Richard Rauck, Richard L. Boortz-Marx, Eric Buchser, Eva Catalá, David A. Bryce,

Annals of Oncology · 2005 · 190 citations · 22 references

DOIFull text

Open access

Concepts

References

22